Anduril will not reach a $75 billion NPM Price reported by Nasdaq Private Market by December 31, 2026. The company will be judged against its June 2025 $30.5 billion valuation and the March 3, 2026 move to seek about $4 billion from Thrive Capital and Andreessen Horowitz, a raise said to nearly dou…